JP Morgan Maintains Overweight on Cellebrite DI, Raises Price Target to $15
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 14 2024
0mins
Source: Newsfilter
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on CLBT
Wall Street analysts forecast CLBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLBT is 24.20 USD with a low forecast of 23.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
6 Buy
0 Hold
1 Sell
Moderate Buy
Current: 16.010
Low
23.00
Averages
24.20
High
25.00
Current: 16.010
Low
23.00
Averages
24.20
High
25.00
About CLBT
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cellebrite (CLBT) to Release Q4 and FY 2025 Financial Results on February 11, 2026
- Earnings Release Announcement: Cellebrite has announced that it will release its Q4 and FY 2025 financial results on February 11, 2026, before the US markets open, which is expected to impact investor confidence.
- Conference Call and Webcast: On the same day at 8:30 AM ET, the company will host a conference call and webcast to discuss the financial results and provide an outlook for 2026, enhancing transparency and investor communication.
- Historical Financial Data Availability: Historical financial tables and supplementary data related to the earnings release will be made available on the company's investor relations website, facilitating in-depth analysis by analysts and investors.
- Technological Context: Cellebrite's technology supports over 7,000 law enforcement agencies and enterprises, accelerating more than 1.5 million legally authorized investigations annually, demonstrating its leadership position and market demand in the digital investigation sector.
Continue Reading
Security Technology Update: Analyst Perspectives from 12 Firms Before the 'Quiet Period'
Analyst Ratings and Price Targets: Needham analysts provided ratings and price targets for various companies, including a "Buy" for Backblaze, Cellebrite, Datadog, JFrog, N-Able, Tenable, and Varonis, while Fortinet and Check Point received "Hold" ratings.
Company Performance Insights: Key takeaways from the meetings highlighted that Backblaze is in phase 2 of its market transformation, Cellebrite expects growth to reaccelerate in 2026, and Fortinet aims to boost service revenue growth in the latter half of 2026.
Stock Price Movements: Several stocks saw price increases, including Backblaze (+4.88%) and Datadog (+1.80%), while Fortinet's stock declined slightly by 0.14%.
Future Expectations: Companies like DigitalOcean and Dynatrace are preparing for future growth with new data center capacity and expected net new ARR reacceleration, respectively, while ServiceNow faces challenges with AI and M&A risks.
Continue Reading